July 25, 2023

AMTE Power secures £1 million loan facility

AMTE Power Plc (LON:AMTE), a leading developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets, has announced that it has agreed a new secured £1.0 million loan..

BlackRock World Mining Trust: Gold, an important ballast and source of diversification

Can the market’s gold fever continue? The gold price has been rising, fuelled by a weaker Dollar and rising geopolitical tensions. Olivia Markham, manager on the BlackRock World Mining Trust..

ECO Animal Health Group robust performance with encouraging growth in revenues (VIDEO)

ECO Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk to discuss results for the year ended 31st March 2023. David talks us through the highlights, explains what was..

Games Workshop Group report highest level of sales since flotation 29 years ago

Games Workshop Group PLC (LON:GAW) has announced its annual report for the 52 week period to 28 May 2023. Highlights         52 week period to28 May 2023..

Bridgepoint Group announces a strong first half of 2023

Bridgepoint Group (LON:BPT) announced a strong first half of 2023 despite macro volatility with significant growth in underlying income and fee related earnings. Key highlights include: Financials • Fee paying..

Active Energy Group awarded additional CoalSwitch production patent

Active Energy plc (LON:AEG, OTCQB:ATGVF), the international biomass based renewable energy business, has announcd it has been awarded a further patent from the US Patent and Trademark Office with respect..

Actual Experience second enterprise sale of new DWMP product

Actual Experience plc (LON:ACT), the analytics-as-a-service company, has announced that it has received a second order for its Digital Workplace Management Platform (DWMP) within 9 months of commercial launch. This..

N4 Pharma granting of patent application in the United States

N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has announced two operational updates. Granting of further US patent The..

hVIVO plc £13.1m contract to develop an influenza B virus challenge model

hVIVO plc (LON:HVO), the world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced a £13.1m contract with an existing top five global pharmaceutical..

Search

Funds

July 25, 2023

Search

Funds

July 25, 2023

FTSE 100

Funds